| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.25 | 0.01 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |